hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06296199, orgStudyIdInfo id: 2024-2064, briefTitle: Music, Virtual Reality for Inpatients in IUGM, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-05, primaryCompletionDateStruct date: 2024-12, completionDateStruct date: 2025-05, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal, class: OTHER_GOV, descriptionModule briefSummary: Promoting good care, well-being and quality of life for geriatric patients is a long-standing initiative in Quebec, and one in which the Institut Universitaire de Gériatrie de Montréal (IUGM) has always been a leader. For example, the IUGM played a major role in drafting the reference framework for the AAPA (approach adapted to the needs of the elderly), which was introduced by the Ministère de la Santé et des Services Sociaux in 2011. The investigator propose to continue this work by focusing in this project on the development of a new intervention aimed at the well-being and quality of life of geriatric patients and based on music and VR.Thee investigator hypothesize (1) that a VR headset-based intervention based on listening to and observing a concert of musicians playing classical music is feasible for patients hospitalized at the IUGM's URFI, and (2) that this intervention can improve their mental health - i.e. their positive emotions, well-being and quality of life - and reduce their anxiety., conditionsModule conditions: Aging, conditions: Disorder, Neurologic, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: OTHER, maskingInfo masking: NONE, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: VR, interventions name: Music only, outcomesModule primaryOutcomes measure: Feasability, secondaryOutcomes measure: Emotions variation, secondaryOutcomes measure: Affect variation, secondaryOutcomes measure: Well-Being Variation, secondaryOutcomes measure: Quality of life variation, secondaryOutcomes measure: Anxiety variation, eligibilityModule sex: ALL, minimumAge: 60 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06296147, orgStudyIdInfo id: STUDY23080006, briefTitle: Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-10, primaryCompletionDateStruct date: 2024-11-01, completionDateStruct date: 2024-11-01, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: University of Pittsburgh, class: OTHER, descriptionModule briefSummary: The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarrassment during and after the procedure between the VR Group, Aromatherapy Group, VR+Aromatherapy Group, and the Control group., conditionsModule conditions: Prostate Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 208, type: ESTIMATED, armsInterventionsModule interventions name: Virtual Reality Headset, interventions name: Aromatherapy Patch, interventions name: Standard of Care, outcomesModule primaryOutcomes measure: Levels of pain, fear, and embarrassment that each group experienced before the TPBx measured using a self-reported survey that asks about experience prior to biopsy. The survey will be provided after the procedure., primaryOutcomes measure: Levels of pain, fear, and embarrassment that each group experienced during the TPBx measured using a self-reported survey that asks about experience during the biopsy. The survey will be provided after the procedure., primaryOutcomes measure: Levels of pain, fear, and embarrassment that each group experienced after the TPBx measured using a self-reported survey that asks about experience after to biopsy. The survey will be provided after the procedure., secondaryOutcomes measure: Proportion of patients undergoing TPBx who would be interested in using a VR device or aromatherapy patch during the procedure., secondaryOutcomes measure: Safety and feasibility of using a VR device or aromatherapy patch during TPBx via the proportion of procedures completed successfully with no major complications or prolongations., eligibilityModule sex: MALE, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Pittsburgh Medical Center Shadyside Hospital, status: RECRUITING, city: Pittsburgh, state: Pennsylvania, zip: 15232, country: United States, contacts name: Divya Natesan, BS, role: CONTACT, email: din15@pitt.edu, contacts name: John Myrga, MD, role: CONTACT, email: myrgajm@upmc.edu, contacts name: Bruce Jacobs, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 40.44062, lon: -79.99589, hasResults: False
protocolSection identificationModule nctId: NCT06296134, orgStudyIdInfo id: 17501, briefTitle: Perineal Massage in Pregnancy to Reduce the Levator Ani Coactivation, acronym: CO-LAM23, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-11, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2025-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Azienda Sanitaria Universitaria Friuli Centrale, class: OTHER, descriptionModule briefSummary: The goal of this clinical trial is to test the efficacy of the perineal massage in reducing the levator ani muscle (LAM) co-activation. This phenomenon is characterized by the LAM contraction rather than its relaxation during the Valsalva maneuver and it is associated with adverse obstetric outcome. Participants who co-activate will be enrolled and randomized in 2 groups: group A, where women themselves perform the perineal massage during the third trimester of pregnancy and group B, where women undergo the standard care. Researchers will compare these groups to see if the perineal massage is able to reduce LAM co-activation., conditionsModule conditions: Pelvic Floor Disorders, conditions: Levator Ani Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 58, type: ESTIMATED, armsInterventionsModule interventions name: perineal massage, outcomesModule primaryOutcomes measure: Comparison of the percentages of women without levator ani muscle co-activation after treatment or after standard care, evaluated at 37-38 weeks of gestation, using chi square test., secondaryOutcomes measure: Evaluation of significant differences in spontaneous or iatrogenic vaginal tears between the groups, secondaryOutcomes measure: percentage of women who completely adhere to perineal massage, i.e. who perform the perineal massage once a day, at least 5 days a week, from 34 gestational weeks until delivery., eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Serena Xodo, city: Udine, zip: 33100, country: Italy, contacts name: Serena Xodo, role: CONTACT, phone: 0432-559699, email: serena.xodo@gmail.com, geoPoint lat: 46.0693, lon: 13.23715, hasResults: False
protocolSection identificationModule nctId: NCT06296108, orgStudyIdInfo id: I05-310-22, briefTitle: Risk Factors for Acute Kidney Injury in Patients Undergoing Arthroplasty, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-01, primaryCompletionDateStruct date: 2022-12-31, completionDateStruct date: 2022-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Ankara University, class: OTHER, descriptionModule briefSummary: The authors aimed to determine the risk factors associated with postoperative acute kidney injury in patients undergoing total joint arthroplasty., conditionsModule conditions: Postoperative Acute Kidney Injury, conditions: Arthroplasty, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 911, type: ACTUAL, armsInterventionsModule interventions name: acute kidney injury, outcomesModule primaryOutcomes measure: Acute kidney injury in patients undergoing arthroplasty surgery, secondaryOutcomes measure: Risk factors causing acute kidney injury in patients undergoing arthroplasty surgery, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Ankara University Medical School Anesthesiology and ICU Department, city: Ankara, country: Turkey, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06296095, orgStudyIdInfo id: KDS-CUD-1, briefTitle: To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2023-08-09, primaryCompletionDateStruct date: 2024-10-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Anhui Provincial Hospital, class: OTHER_GOV, descriptionModule briefSummary: The study is a single-center, single-arm, open-label, dose-escalation clinical study, to evaluate the tolerability, safety and preliminary efficacy of CUD005 injection in patients with cirrhosis, conditionsModule conditions: Cirrhosis, Liver, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SEQUENTIAL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 9, type: ESTIMATED, armsInterventionsModule interventions name: Cell therapy, outcomesModule primaryOutcomes measure: DLT,MTD, secondaryOutcomes measure: fibrosis staging and inflammatory grading, secondaryOutcomes measure: All-cause mortality, secondaryOutcomes measure: TE（Transient elastography）, otherOutcomes measure: MELD（Model for End-stage Liver Disease）, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Anhui province hospital, city: Hefei, state: Anhui, zip: 230000, country: China, geoPoint lat: 31.86389, lon: 117.28083, hasResults: False
protocolSection identificationModule nctId: NCT06296056, orgStudyIdInfo id: SDH-combi, briefTitle: Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-06-01, primaryCompletionDateStruct date: 2025-12-01, completionDateStruct date: 2027-06-01, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Nyamdavaa Tuul, class: OTHER, descriptionModule briefSummary: To evaluate the safety, immune response, and potential efficacy of combined immune cell therapy in patients with stage 4 colorectal cancer who have failed standard treatment and have unresectable lesions or metastatic lesions., conditionsModule conditions: Colorectal Cancer Stage IV, conditions: Metastatic Colorectal Cancer, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: Combi, outcomesModule primaryOutcomes measure: Number of Patients with grade 1-5 adverse events and list of adverse event frequency, primaryOutcomes measure: immune response, primaryOutcomes measure: potential efficacy, eligibilityModule sex: ALL, minimumAge: 19 Years, stdAges: ADULT, stdAges: OLDER_ADULT, hasResults: False
protocolSection identificationModule nctId: NCT06296043, orgStudyIdInfo id: SBU-FUT-01, briefTitle: The Effect of Su-Jok Application and Progressive Muscle Relaxation Exercises in Coping With Premenstrual Syndrome, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-10, primaryCompletionDateStruct date: 2024-07-15, completionDateStruct date: 2024-08-15, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-04-01, sponsorCollaboratorsModule leadSponsor name: Saglik Bilimleri Universitesi, class: OTHER, descriptionModule briefSummary: The aim of this study is to determine the effect of su-jok application and progressive muscle relaxation exercise in coping with premenstrual syndrome., conditionsModule conditions: Premenstrual Syndrome, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Three groups with su-jok group, progressive muscle relaxation exercise group and control group, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: SINGLE, maskingDescription: Double (Participant, Outcomes Assessor) Since the application will be performed by the researcher, participant will be blinded in this study. The statistician will be blinded in the evaluation of the data., whoMasked: PARTICIPANT, enrollmentInfo count: 135, type: ESTIMATED, armsInterventionsModule interventions name: Progressive Muscle Relaxation Exercise Group, interventions name: Su-Jok Intervention, outcomesModule primaryOutcomes measure: PAIN Visual Analog Scale (VAS)- (Min:0 - Max:10), primaryOutcomes measure: FATIGUE Visual Analog Scale (VAS)- (Min:0 - Max:10), primaryOutcomes measure: SLEEP STATE Visual Analog Scale (VAS)- (Min:0 - Max:10), primaryOutcomes measure: NAUSEA VOMITING Visual Analog Scale (VAS)- (Min:0 - Max:10), primaryOutcomes measure: Change in Premenstrual Symptoms (People with PMS scale scores over 104 points will be determined)., eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 30 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06296017, orgStudyIdInfo id: AEŞH- EK1- 2023-115, briefTitle: Effectiveness of Conservative Interventions in the Treatment of Trigger Finger, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-10-02, primaryCompletionDateStruct date: 2024-09, completionDateStruct date: 2024-12, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-04-29, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF., conditionsModule conditions: Trigger Finger, conditions: Stenosing Tenosynovitis, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 54, type: ESTIMATED, armsInterventionsModule interventions name: Experimental: Extracorporeal Shock Wave Therapy, interventions name: Trigger Finger Splint, interventions name: Extracorporeal Shock Wave Therapy+ Trigger Finger Splint, outcomesModule primaryOutcomes measure: Visual analog scale, secondaryOutcomes measure: Grip and pinch strength, secondaryOutcomes measure: Number of trigger, secondaryOutcomes measure: Functional assessment, secondaryOutcomes measure: Treatment satisfaction, secondaryOutcomes measure: Functional assessment, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 65 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Feray Karademir, status: RECRUITING, city: Ankara, zip: 06100, country: Turkey, contacts name: Feray Karademir, role: CONTACT, phone: 90 505 313 75 82, email: karademirferay@gmail.com, contacts name: Feray Karademir, role: CONTACT, geoPoint lat: 39.91987, lon: 32.85427, hasResults: False
protocolSection identificationModule nctId: NCT06296004, orgStudyIdInfo id: CAPILLAROSCOPY behcet disease, briefTitle: Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease Relation Between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2025-03-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Assiut University, class: OTHER, descriptionModule briefSummary: Relation between Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness in Behçet's Disease, conditionsModule conditions: Behçet's Disease, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: PROSPECTIVE, enrollmentInfo count: 80, type: ESTIMATED, armsInterventionsModule interventions name: Nail Fold Capillaroscopy, Optical Coherence Tomography Angiography, and Femoral Vein Wall Thickness by U.S, outcomesModule primaryOutcomes measure: measuring parameter of Nail Fold Capillaroscopy in behcet disease, primaryOutcomes measure: measuring parameter of Optical Coherence Tomography Angiography in behcet disease, primaryOutcomes measure: measuring parameter of Femoral Vein Wall Thickness in behcet disease, secondaryOutcomes measure: relation between Nail Fold Capillaroscopy and activity of behcet disease, secondaryOutcomes measure: relation between Optical Coherence Tomography Angiography and activity of behcet disease, secondaryOutcomes measure: relation between Femoral Vein Wall Thickness and activity of behcet disease, eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 60 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06295991, orgStudyIdInfo id: 2023/005, briefTitle: The Effect of Lycra Garments on Spastic Diplegic Cerebral Palsy Patients With Scoliosis, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-03-21, completionDateStruct date: 2024-07-30, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Hacettepe University, class: OTHER, descriptionModule briefSummary: The primary aim of this study was to investigate the effects of lycra clothing on balance and respiratory functions in individuals with cerebral palsy with scoliosis, and the secondary aim was to investigate the effects of lycra clothing on motor function, activity limitation and quality of life in these individuals., conditionsModule conditions: Balanced; Rearrangement, conditions: Respiratory Function Test, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SCREENING, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 24, type: ESTIMATED, armsInterventionsModule interventions name: Lycra garment, outcomesModule primaryOutcomes measure: Balance parameters, primaryOutcomes measure: Respiratory functions, primaryOutcomes measure: Respiratory muscle strength measurement, secondaryOutcomes measure: Gross motor function measurement, secondaryOutcomes measure: Functional independence assessment, secondaryOutcomes measure: Assessment of activity restriction, secondaryOutcomes measure: Quality of life assessment, secondaryOutcomes measure: Assessment of posture, eligibilityModule sex: ALL, minimumAge: 10 Years, maximumAge: 18 Years, stdAges: CHILD, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06295978, orgStudyIdInfo id: 4896, briefTitle: Multimarker Approach in Acute Chest Pain, statusModule overallStatus: RECRUITING, startDateStruct date: 2021-02-01, primaryCompletionDateStruct date: 2024-05-31, completionDateStruct date: 2024-12-31, studyFirstPostDateStruct date: 2024-03-06, lastUpdatePostDateStruct date: 2024-03-06, sponsorCollaboratorsModule leadSponsor name: Fondazione Policlinico Universitario Agostino Gemelli IRCCS, class: OTHER, descriptionModule briefSummary: Chest pain is one of the most common causes of access in the Emergency Room, and it can be a clinical manifestation of a broad spectrum of diseases including those 'time dependent' conditions such as acute coronary syndrome (ACS). Diagnosis or exclusion of acute myocardial infarction (AMI) is a daily challenge in the emergency department (ED), especially when classic clinical criteria and ECG alone are unable to make the diagnosis. The ED physician has the extremely delicate task of managing patients with chest pain and being able to frame them correctly; therefore, he needs to make differential diagnosis since chest pain can be caused by non-cardiac vascular events but also extra-cardiovascular events, such as pulmonary, neurological, osteoarticular, gastrointestinal and psychological. Recently, the importance of inflammatory processes and endothelial damage in cardiovascular disease has been highlighted, and consequently the focus has been on new markers, in a "multimarker" approach in which the strengths of each are combined together to provide an optimal solution to a clinical problem.The data suggest how a future integration of these biomarkers in the routine approach to the patient with acute chest pain in the ED might allow a better patient stratification and proper management, allowing the clinician to make an early safe discharge or a timely admission for those who deserve in-depth diagnostic-therapeutic investigation., conditionsModule conditions: Cardiovascular Disease Other, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 250, type: ESTIMATED, armsInterventionsModule interventions name: Biochemical marker assays, outcomesModule primaryOutcomes measure: The predictive value of markers for the risk of cardiovascular events in chest pain, secondaryOutcomes measure: Multimarker approach to improve cardiovascular risk stratification, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione Policlinico Universitario "A. Gemelli" IRCCS, status: RECRUITING, city: Roma, zip: 00168, country: Italy, contacts name: ANDREA PICCIONI, Dr., role: CONTACT, phone: 0630153161, email: andrea.piccioni@policlinicogemelli.it, geoPoint lat: 41.89193, lon: 12.51133, hasResults: False